| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.49 | 0.09 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.41 | 0.01 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.32 | 0.05 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.3 | 0.05 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.28 | 0.07 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.27 | 0.3 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.26 | 0.4 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.25 | 0.1 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.24 | 0.1 |